Financhill
Sell
24

AEMD Quote, Financials, Valuation and Earnings

Last price:
$0.38
Seasonality move :
-13.22%
Day range:
$0.37 - $0.43
52-week range:
$0.24 - $1.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.25x
Volume:
276.1K
Avg. volume:
377.3K
1-year change:
-77.89%
Market cap:
$5.4M
Revenue:
$574.3K
EPS (TTM):
-$1.58

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
AEMD
Aethlon Medical
-- -$0.20 -100% -84.98% $3.88
CATX
Perspective Therapeutics
-- -$0.30 -- -41.72% $15.58
QDEL
QuidelOrtho
$626.5M $0.13 -1.93% 480.41% $51.14
VNRX
VolitionRX
$1M -$0.05 123.53% -51.52% $3.37
VTAK
Catheter Precision
$600K -$0.18 118.75% -11.57% --
XTNT
Xtant Medical Holdings
$32.3M -$0.02 9.96% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
AEMD
Aethlon Medical
$0.37 $3.88 $5.4M -- $0.00 0% --
CATX
Perspective Therapeutics
$2.59 $15.58 $175.1M -- $0.00 0% 13.99x
QDEL
QuidelOrtho
$36.12 $51.14 $2.4B -- $0.00 0% 0.87x
VNRX
VolitionRX
$0.56 $3.37 $52M -- $0.00 0% 36.22x
VTAK
Catheter Precision
$0.38 -- $3.1M 0.44x $0.00 0% 1.03x
XTNT
Xtant Medical Holdings
$0.48 $1.75 $66.8M -- $0.00 0% 0.55x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
AEMD
Aethlon Medical
-- -3.781 -- --
CATX
Perspective Therapeutics
-- -3.661 -- --
QDEL
QuidelOrtho
45.42% 1.384 82.87% 0.55x
VNRX
VolitionRX
-28.76% -0.785 8.83% 0.19x
VTAK
Catheter Precision
12% -2.395 128.21% 0.53x
XTNT
Xtant Medical Holdings
44.29% 0.232 55.45% 0.94x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
AEMD
Aethlon Medical
-- -$1.8M -- -- -- -$2M
CATX
Perspective Therapeutics
-- -$18.6M -- -- -- -$26.3M
QDEL
QuidelOrtho
$326.1M $15.2M -34.12% -58.1% -13.59% $16.5M
VNRX
VolitionRX
-- -$5.8M -- -- -1217.88% -$5.5M
VTAK
Catheter Precision
$86K -$2.9M -63.93% -65.84% -4258.33% -$2.8M
XTNT
Xtant Medical Holdings
$16M -$1.9M -21.41% -35.34% -6.38% -$7K

Aethlon Medical vs. Competitors

  • Which has Higher Returns AEMD or CATX?

    Perspective Therapeutics has a net margin of -- compared to Aethlon Medical's net margin of --. Aethlon Medical's return on equity of -- beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AEMD
    Aethlon Medical
    -- -$0.13 --
    CATX
    Perspective Therapeutics
    -- -$0.21 --
  • What do Analysts Say About AEMD or CATX?

    Aethlon Medical has a consensus price target of $3.88, signalling upside risk potential of 936.96%. On the other hand Perspective Therapeutics has an analysts' consensus of $15.58 which suggests that it could grow by 501.43%. Given that Aethlon Medical has higher upside potential than Perspective Therapeutics, analysts believe Aethlon Medical is more attractive than Perspective Therapeutics.

    Company Buy Ratings Hold Ratings Sell Ratings
    AEMD
    Aethlon Medical
    0 1 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is AEMD or CATX More Risky?

    Aethlon Medical has a beta of 1.804, which suggesting that the stock is 80.435% more volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.251, suggesting its more volatile than the S&P 500 by 25.149%.

  • Which is a Better Dividend Stock AEMD or CATX?

    Aethlon Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AEMD or CATX?

    Aethlon Medical quarterly revenues are --, which are smaller than Perspective Therapeutics quarterly revenues of --. Aethlon Medical's net income of -$1.8M is higher than Perspective Therapeutics's net income of -$15.1M. Notably, Aethlon Medical's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical is -- versus 13.99x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AEMD
    Aethlon Medical
    -- -- -- -$1.8M
    CATX
    Perspective Therapeutics
    13.99x -- -- -$15.1M
  • Which has Higher Returns AEMD or QDEL?

    QuidelOrtho has a net margin of -- compared to Aethlon Medical's net margin of -25.21%. Aethlon Medical's return on equity of -- beat QuidelOrtho's return on equity of -58.1%.

    Company Gross Margin Earnings Per Share Invested Capital
    AEMD
    Aethlon Medical
    -- -$0.13 --
    QDEL
    QuidelOrtho
    46.07% -$2.28 $5.5B
  • What do Analysts Say About AEMD or QDEL?

    Aethlon Medical has a consensus price target of $3.88, signalling upside risk potential of 936.96%. On the other hand QuidelOrtho has an analysts' consensus of $51.14 which suggests that it could grow by 41.59%. Given that Aethlon Medical has higher upside potential than QuidelOrtho, analysts believe Aethlon Medical is more attractive than QuidelOrtho.

    Company Buy Ratings Hold Ratings Sell Ratings
    AEMD
    Aethlon Medical
    0 1 0
    QDEL
    QuidelOrtho
    2 3 0
  • Is AEMD or QDEL More Risky?

    Aethlon Medical has a beta of 1.804, which suggesting that the stock is 80.435% more volatile than S&P 500. In comparison QuidelOrtho has a beta of 0.097, suggesting its less volatile than the S&P 500 by 90.311%.

  • Which is a Better Dividend Stock AEMD or QDEL?

    Aethlon Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QuidelOrtho offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical pays -- of its earnings as a dividend. QuidelOrtho pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AEMD or QDEL?

    Aethlon Medical quarterly revenues are --, which are smaller than QuidelOrtho quarterly revenues of $707.8M. Aethlon Medical's net income of -$1.8M is higher than QuidelOrtho's net income of -$178.4M. Notably, Aethlon Medical's price-to-earnings ratio is -- while QuidelOrtho's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical is -- versus 0.87x for QuidelOrtho. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AEMD
    Aethlon Medical
    -- -- -- -$1.8M
    QDEL
    QuidelOrtho
    0.87x -- $707.8M -$178.4M
  • Which has Higher Returns AEMD or VNRX?

    VolitionRX has a net margin of -- compared to Aethlon Medical's net margin of -1226.82%. Aethlon Medical's return on equity of -- beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AEMD
    Aethlon Medical
    -- -$0.13 --
    VNRX
    VolitionRX
    -- -$0.07 -$17.8M
  • What do Analysts Say About AEMD or VNRX?

    Aethlon Medical has a consensus price target of $3.88, signalling upside risk potential of 936.96%. On the other hand VolitionRX has an analysts' consensus of $3.37 which suggests that it could grow by 501.2%. Given that Aethlon Medical has higher upside potential than VolitionRX, analysts believe Aethlon Medical is more attractive than VolitionRX.

    Company Buy Ratings Hold Ratings Sell Ratings
    AEMD
    Aethlon Medical
    0 1 0
    VNRX
    VolitionRX
    2 1 0
  • Is AEMD or VNRX More Risky?

    Aethlon Medical has a beta of 1.804, which suggesting that the stock is 80.435% more volatile than S&P 500. In comparison VolitionRX has a beta of 1.092, suggesting its more volatile than the S&P 500 by 9.182%.

  • Which is a Better Dividend Stock AEMD or VNRX?

    Aethlon Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AEMD or VNRX?

    Aethlon Medical quarterly revenues are --, which are smaller than VolitionRX quarterly revenues of $474.5K. Aethlon Medical's net income of -$1.8M is higher than VolitionRX's net income of -$5.8M. Notably, Aethlon Medical's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical is -- versus 36.22x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AEMD
    Aethlon Medical
    -- -- -- -$1.8M
    VNRX
    VolitionRX
    36.22x -- $474.5K -$5.8M
  • Which has Higher Returns AEMD or VTAK?

    Catheter Precision has a net margin of -- compared to Aethlon Medical's net margin of -4291.67%. Aethlon Medical's return on equity of -- beat Catheter Precision's return on equity of -65.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    AEMD
    Aethlon Medical
    -- -$0.13 --
    VTAK
    Catheter Precision
    89.58% -$2.01 $14.6M
  • What do Analysts Say About AEMD or VTAK?

    Aethlon Medical has a consensus price target of $3.88, signalling upside risk potential of 936.96%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 419.62%. Given that Aethlon Medical has higher upside potential than Catheter Precision, analysts believe Aethlon Medical is more attractive than Catheter Precision.

    Company Buy Ratings Hold Ratings Sell Ratings
    AEMD
    Aethlon Medical
    0 1 0
    VTAK
    Catheter Precision
    0 0 0
  • Is AEMD or VTAK More Risky?

    Aethlon Medical has a beta of 1.804, which suggesting that the stock is 80.435% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.541, suggesting its less volatile than the S&P 500 by 154.132%.

  • Which is a Better Dividend Stock AEMD or VTAK?

    Aethlon Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AEMD or VTAK?

    Aethlon Medical quarterly revenues are --, which are smaller than Catheter Precision quarterly revenues of $96K. Aethlon Medical's net income of -$1.8M is higher than Catheter Precision's net income of -$4.1M. Notably, Aethlon Medical's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical is -- versus 1.03x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AEMD
    Aethlon Medical
    -- -- -- -$1.8M
    VTAK
    Catheter Precision
    1.03x 0.44x $96K -$4.1M
  • Which has Higher Returns AEMD or XTNT?

    Xtant Medical Holdings has a net margin of -- compared to Aethlon Medical's net margin of -10.04%. Aethlon Medical's return on equity of -- beat Xtant Medical Holdings's return on equity of -35.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    AEMD
    Aethlon Medical
    -- -$0.13 --
    XTNT
    Xtant Medical Holdings
    50.85% -$0.02 $77.1M
  • What do Analysts Say About AEMD or XTNT?

    Aethlon Medical has a consensus price target of $3.88, signalling upside risk potential of 936.96%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 264.58%. Given that Aethlon Medical has higher upside potential than Xtant Medical Holdings, analysts believe Aethlon Medical is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    AEMD
    Aethlon Medical
    0 1 0
    XTNT
    Xtant Medical Holdings
    2 0 0
  • Is AEMD or XTNT More Risky?

    Aethlon Medical has a beta of 1.804, which suggesting that the stock is 80.435% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.747%.

  • Which is a Better Dividend Stock AEMD or XTNT?

    Aethlon Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AEMD or XTNT?

    Aethlon Medical quarterly revenues are --, which are smaller than Xtant Medical Holdings quarterly revenues of $31.5M. Aethlon Medical's net income of -$1.8M is higher than Xtant Medical Holdings's net income of -$3.2M. Notably, Aethlon Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical is -- versus 0.55x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AEMD
    Aethlon Medical
    -- -- -- -$1.8M
    XTNT
    Xtant Medical Holdings
    0.55x -- $31.5M -$3.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock